NCT07104331 2026-03-03SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic Epithelioid HemangioendotheliomaSarcoma Alliance for Research through CollaborationPhase 2 Recruiting41 enrolled